B-cell prolymphocytic leukemia natural history, complications and prognosis: Difference between revisions

	B-cell prolymphocytic leukemia
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating B-cell prolymphocytic leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Biopsy
X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
B-cell prolymphocytic leukemia natural history, complications and prognosis On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of B-cell prolymphocytic leukemia natural history, complications and prognosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on B-cell prolymphocytic leukemia natural history, complications and prognosis
CDC on B-cell prolymphocytic leukemia natural history, complications and prognosis
B-cell prolymphocytic leukemia natural history, complications and prognosis in the news
Blogs on B-cell prolymphocytic leukemia natural history, complications and prognosis
Directions to Hospitals Treating B-cell prolymphocytic leukemia
Risk calculators and risk factors for B-cell prolymphocytic leukemia natural history, complications and prognosis

Revision as of 14:03, 13 October 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Carlos A Lopez, M.D. [2]

The prognosis for B-cell prolymphocytic leukemia is generally poor.

The prognosis for B-cell prolymphocytic leukemia is generally poor. But usually has a better prognosis than T-cell prolymphocytic leukemia^[1]^[2].

↑ Del Giudice I, Davis Z, Matutes E; et al. (2006). "IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL)". Leukemia. 20 (7): 1231–7. doi:10.1038/sj.leu.2404238. PMID 16642047.
↑ "Canadian Cancer Society".

@@ Line 7: / Line 7: @@
 ==Prognosis==
-The prognosis for B-cell prolymphocytic leukemia is generally poor. But usually has a better prognosis than T-cell prolymphocytic leukemia.<ref name="pmid16642047">{{cite journal |author=Del Giudice I, Davis Z, Matutes E, ''et al'' |title=IgVH genes mutation and usage, [[ZAP-70]] and [[CD38]] expression provide new insights on B-cell prolymphocytic leukemia (B-PLL) |journal=Leukemia |volume=20 |issue=7 |pages=1231-7 |year=2006 |pmid=16642047 |doi=10.1038/sj.leu.2404238}}</ref><ref name=T-PLL>{{cite web | title = Canadian Cancer Society| url =http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/prolymphocytic-leukemias/?region=on }}</ref>.
+The prognosis for B-cell prolymphocytic leukemia is generally poor. But usually has a better prognosis than T-cell prolymphocytic leukemia<ref name="pmid16642047">{{cite journal |author=Del Giudice I, Davis Z, Matutes E, ''et al'' |title=IgVH genes mutation and usage, [[ZAP-70]] and [[CD38]] expression provide new insights on B-cell prolymphocytic leukemia (B-PLL) |journal=Leukemia |volume=20 |issue=7 |pages=1231-7 |year=2006 |pmid=16642047 |doi=10.1038/sj.leu.2404238}}</ref><ref name=T-PLL>{{cite web | title = Canadian Cancer Society| url =http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/prolymphocytic-leukemias/?region=on }}</ref>.
 ==References==